JUL 13, 2017 3:22 PM PDT

Nanoparticles Take aim at Antibiotic-resistant Bacteria

WRITTEN BY: Carmen Leitch

Researchers are trying a new approach to fight antibiotic-resistant bacteria; they have placed an antibiotic layer around nanoparticles made up of silver and silica. While silica could be toxic to human cells, the chemical properties of this newly created nanopharmaceutical only affect pathogens and are harmless to organisms.

Silver-silica nanoparticles with an ampicillin coating are safe for human cells and lethal to antibiotic-resistant microorganisms. / Credit: Mateus Borba Cardoso

"We used the antibiotic as a sort of bait to have the nanoparticles target the bacteria with a significant amount of the drug. The combined action of the drug with the silver ions proved capable of killing even resistant microorganisms," explained Mateus Borba Cardoso, a researcher at the National Energy & Materials Research Center (CNPEM).

This work, published in Scientific Reports, is part of a bigger plan to examine ways to create nanoparticles with selective efficacy. Previous research has shown that chemotherapy could be improved upon with nanoparticles that carry anti-cancer drugs right to malignant cells while ignoring healthy cells. This work could have implications for HIV as well; nanoparticles may be able to inactivate the virus in blood supplies, for example.

"There are commercial drugs that contain nanoparticles, which typically serve to coat the active ingredient and extend its lifetime inside the organism. Our strategy is different. We decorate the surface of the nanoparticles with particular chemical groups that direct them to the site where they're designed to act, so they're highly selective," Cardoso explained.

For this new work, the investigators developed a plan to make nanoparticles using a silver core that is coated with a porous silica, which allows ions to move through. An antibiotic - Ampicillin - was also carefully arranged on the surface in a very particular way, for a specific reason, Cardoso said.

"We used molecular modeling to find out which part of the ampicillin molecule interacted most with the bacterial membrane," he said. "We then arranged all the molecules of the drug so that this key part was facing outward from the nanoparticle, increasing the likelihood of interaction with the pathogen."

With two different bacterial strains, the researchers next compared the efficacy of the synthesized nanoantibiotic. The researchers used a bacterium that can cause food poisoning but usually lives in the human digestive tract, Escherichia coli. One of the strains was a non-resistant strain, and when exposed to either drug, all the bacteria died. In the strain that carried antibiotic-resistance, only the nanoantibiotic was able to destroy the bacteria.

The investigators evaluated the safety of the synthesized nanoparticle, finding that the coated particle was not dangerous to human kidney cells. However, nanoparticles that weren't coated with ampicillin were very toxic.

"Confocal microscopy images show that besides being non-toxic, the nanoparticle coated with ampicillin doesn't interfere with the cell cycle. The phases of mitosis take their course without any alterations," Cardoso said. He suggested that it may be possible to use this same strategy to fight other resistant bacteria. It could also be possible to add different drugs to the surface of the nanoparticle. However, these nanoparticles are inorganic, meaning they could accumulate inside of an organism, like people, over time.

"We don't yet know where the build-up occurs or what effect it has," Cardoso noted. "To find out, we'll need to do tests in animals. In any event, we're continuing to improve the system to make it safer."

Using something other than a silver core is one potential solution, or creating a nanoparticle that is so small, it passes in urine. However, Cardoso said the nanoparticle is useful right now in the treatment of dire cases that are not responding to any treatments.

Check out the video above for more on targeted therapies using nanopharmaceuticals.

 

Sources: AAAS/Eurekalert! via FAPESP, Scientific Reports

 

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 15, 2019
Cell & Molecular Biology
DEC 15, 2019
Using a Bacterial Syringe to Deliver Proteins to Cells
Researchers want to use a pathogen's strategy for therapeutic purposes....
DEC 15, 2019
Microbiology
DEC 15, 2019
Neurons in the Gut Can Detect Salmonella & Protect Against Infection
Nerve cells act as critical sensors for the human body, and now scientists have found that they have another role in the small intestine....
DEC 18, 2019
Clinical & Molecular DX
DEC 18, 2019
Germs don't stand a chance with new AI-powered diagnostic platform
We are steadily losing our edge in the war against infectious bacteria. A huge surge in antibiotic resistance is threatening healthcare and agricultural in...
JAN 17, 2020
Cardiology
JAN 17, 2020
Eating Walnuts Reduces Risk for Heart Disease
Walnuts may be more than just a tasty snack. Researchers from the University of Pennsylvania have found that they may also promote healthy gut bacteria, wh...
FEB 14, 2020
Microbiology
FEB 14, 2020
Beneath the Surface, We All Carry the Same Microbes in Our Skin
Our skin is a critical barrier, and it is made up of three layers. It also carries a community of microbes - a skin microbiome....
FEB 19, 2020
Immunology
FEB 19, 2020
Rainbow trout hold the key to unravelling immunological mysteries
What do the gut microbiome, antibodies, and rainbow trout have in common? A lot, says researcher J. Oriol Sunyer from the University of Pennsylvania’...
Loading Comments...